Jpmorgan Chase & Co »

Foghorn Therapeutics shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Foghorn Therapeutics (FHTX) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Foghorn Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Foghorn Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Foghorn Therapeutics by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $85k 13k 6.45
2023-09-30 $105k 21k 5.00
2023-06-30 $120k 17k 7.04
2023-03-31 $146k 16k 9.43
2022-12-31 $73k 11k 6.42
2022-06-30 $146k 11k 13.59
2022-03-31 $140k 9.2k 15.26
2021-12-31 $172k 7.5k 22.90
2021-03-31 $267k 20k 13.35
2020-12-31 $399k 20k 20.30